Post

Merck KGaA links with BenevolentAI and Exscientia to expand AI capabilities

Merck KGaA has announced two new strategic partnerships with Benevolent AI and Exscientia to support its artificial intelligence (AI)-driven drug …

ADDF invest in BrainScope for Alzheimer’s prediction biomarker

BrainScope has announced an investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in an ongoing Series B round to pursue …

ARS hits roadblock for neffy approval as FDA requests additional study

The US Food and Drug Administration (FDA) has asked for repeat-dose study results before granting approval for ARS Pharmaceuticals’s neffy …

Drug manufacturing automation key as populations age, says Lotte Biologics CEO 

Widespread adoption of automation in drug manufacturing is key to addressing the healthcare issues that affect ageing populations, said Lotte …

Signal: UK NHS pay row intensifies as doctors launch joint strike

UK consultants and junior doctors walked out today (20 September) for joint strike action, the first in the National Health …